Prosecution Insights
Last updated: May 29, 2026
Application No. 17/662,903

IMPLANT SYSTEMS AND METHODS EMPLOYING A MOBILE GLENOSPHERE

Final Rejection §102
Filed
May 11, 2022
Priority
Nov 14, 2019 — provisional 62/935,432 +1 more
Examiner
WHITE, KIA XIONG
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Ignite Orthopedics LLC
OA Round
2 (Final)
65%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
26 granted / 40 resolved
-5.0% vs TC avg
Strong +52% interview lift
Without
With
+51.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
13 currently pending
Career history
68
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
84.3%
+44.3% vs TC avg
§102
7.6%
-32.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 40 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-7, 13-16, 20-25, 36-40, 43-52 are pending and examined below. Claims 26-35 is/are withdrawn. Response to Arguments Applicant's arguments filed 12/01/2025 have been fully considered but they are not persuasive. Applicant argues that the amendments to the independent claims overcome the rejections of record (pages 12-13) and that the dependent claims rise and fall with the same arguments (page 13). The drawing objection is withdrawn. There was not a specification objection in the office action mailed on August 1, 2025. In regards to claim 1, the applicant argues that the prior art, Angibaud, does not teach, “the second portion having at least one curved surface positioned adjacent to the central axis” as amended. The applicant argues that the glenosphere (108) includes a bottom recessed track area (118) recessed into the glenosphere with a flat interior surface for both recessed regions (page 12). The applicant also argues that the glenosphere (108) also includes a second circular shaped recess inside the bottom recessed track (118) which has a flat interior surface (page 12). The examiner respectfully disagree. Angibaud discloses in Fig. 5B curved surfaces (top and bottom portions of second portion, see annotated Fig. 5B below) on the second portion of 108. Angibaud further discloses in Figs. 6-10, the plate 110 with ring 130 when assembled together in Fig. 8C, appears to be in a curved orientation from the side view. Furthermore, Angibaud discloses that “the glenosphere body has a perimeter shape that is generally circular to substantially match a perimeter shape of the glenoid plate” (¶0045, Angibaud), thus, Figs. 5B, 8C, and the disclosure of ¶0045 would inherently disclose “the second portion having at least one curved surface positioned adjacent to the central axis” as amended in claim 1. In regards to claim 16, the applicant argues that Angibaud fails to disclose the second portion having a curved recessed slot extending into the second portion (page 13). The examiner respectfully disagrees. Angibaud discloses 118 (Fig. 5B) where the second portion of the glenosphere (108) having a “curved recessed slot extending into the second portion” as the claimed invention. 118 is a recessed track which extends into the second portion of 108 (Figs. 5B and 11-12). The disclosures of Angibaud reads on the amended claimed invention. Therefore, the applicant’s argument is not sufficient to overcome the rejection of record and the claims remains rejected. Claim Rejections - 35 USC § 102 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 1-7, 13-16, 20-25, 36-40, 43-52 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Angibaud et al. (US 20120209392 A1) hereinafter, Angibaud. Regarding claim 1, Angibaud teaches a glenoid implant system (100, Figs. 4A-4C, ¶0044) for use in a reverse total shoulder replacement (100, Fig. 4A-4C, ¶0044) in a patient, said glenoid implant system comprising: a glenosphere (108, Figs. 5A-5C) comprising a body having a first portion and a second portion (see annotated Figs. 5A-5C below), said first portion having an articular surface (Fig. 5C), and said body (Fig. 5B) defining a central axis extending from said first portion to said second portion (Fig. 5A); and the second portion having at least one curved surface positioned adjacent to the central axis (top and bottom portions of second portion are curved, see annotated Fig. 5B below); a baseplate (110, Fig. 11A) fixedly attachable to a glenoid of the patient (Fig, 3A), said baseplate (110, Figs. 6A-6D) having a body defining a central axis (Fig. 6C); a connector (140, Fig. 10C) for movably connecting said glenosphere (108, Fig. 10B) to said baseplate (110, Fig. 10C); and wherein said glenosphere (108, Fig. 10B) and said baseplate (110, Fig. 10C) are operably configured so that said central axis of said glenosphere is movable non-axially relative to said central axis of said baseplate (¶0049). Regarding claim 2, Angibaud teaches wherein said central axis of said glenosphere (108, Figs. 11A-12B) is tiltably movable relative to said central axis of said baseplate (Figs. 11A-12B, ¶0051). Regarding claim 3, Angibaud teaches wherein said central axis of said glenosphere is tiltably movable over a range of between 10 degrees and 30 degrees relative to said central axis of said baseplate (12 degrees in each direction, 24 degrees in total, ¶0051). Regarding claim 4, Angibaud teaches wherein the at least one curved surface of said second portion (top and bottom portions of 118 are curved, Fig. 5B) of said glenosphere comprises a convex surface (outer hemisphere of second portion is convex and faces baseplate 100, see annotated Figs. 5A-5C below) facing said baseplate (110, Fig. 10C). Regarding claim 5, Angibaud teaches wherein said body of said glenosphere (108, Figs. 5A-5C) comprises a passageway (seen in Fig. 5B) from said first portion to said second portion, and said connector (140, Fig. 10C) is extendable through said passageway for movably connecting said glenosphere (108, Fig. 10B) relative to said baseplate (110, Fig 10C). Regarding claim 6, Angibaud teaches wherein said passageway (seen in Fig. 5B) comprises a cylindrical portion (circular portion seen in Fig. 5B), a track portion (118, Fig. 5B), and expanded portion (portion between circular portion and 118, Fig. 5B) extending from said cylindrical portion to said track portion (Fig. 5B, ¶0045), and wherein a first curved surface of the at least one curved surface of the second portion is positioned on a first side of the track portion and a second curved surface of the at least one curved surface of the second portion is positioned on a second side of the track portion, wherein the first side is positioned opposite the second side (Fig. 5B). Regarding claim 7, Angibaud teaches wherein said expanded portion of said passageway comprises parallel sidewalls (Fig. 5A). Regarding claim 13, Angibaud teaches further comprising a humeral implant system (Figs. 4A-4C). Regarding claim 14, Angibaud teaches wherein said humeral implant system (Figs. 4A-4C) comprises a humeral cup (104, Figs. 4A-4C) and a humeral stem (102, Figs. 4A-4C). Regarding claim 15, Angibaud teaches wherein said glenoid implant system comprises a central screw (112, Fig. 6C) and a plurality of peripheral screws (114, Fig. 8C) for securing said baseplate (110, Fig. 8C) to the glenoid of the patient (Fig. 11A, ¶0047). Regarding claim 16, Angibaud teaches a glenoid implant system (100, Figs. 4A-4C, ¶0044) for use in a reverse total shoulder replacement (100, Figs. 4A-4C, ¶0044) of a patient, said glenoid implant system comprising: a glenosphere (108, Figs. 5A-5C) comprising a body (Fig. 5B) with an articular surface (Fig. 5C), the body having a first portion and a second portion (see annotated Figs. 5A-5C below), the first portion having the articular surface (Fig. 5C), the second portion having a curved recessed slot extending into the second portion (118 forms a recessed track extending into second portion, Fig. 5B, ¶0045), wherein the curved recessed slot is curved relative to the articular surface of the first portion (118 is a recessed track which extends into the second portion of 108 and curved relative to the articular surface since ¶0045 discloses glenosphere body has a perimeter shape that is generally circular to substantially match a perimeter shape of the glenoid plate and Fig. 8C shows 110 with 130 rounded/curved (from the side view) relative to the articular surface of 108 in Fig. 10C, (Figs. 5B, 8C, 10C, and 11-12, ¶0045)); a baseplate (110, Fig. 11A) fixedly attachable to a glenoid of the patient (Fig, 3A), said baseplate (110, Figs. 6A-6D) having a central axis (Fig. 6C); and a means (140, Fig. 10C) for movably connecting said glenosphere to said baseplate (108, Fig. 10B), wherein said glenosphere (108, Fig. 10B) is movable non-coaxially relative to said baseplate (¶0049). Regarding claim 20, Angibaud teaches wherein said glenosphere (108, Fig. 10B) is rotatable about a pivot axis (142, Figs. 9A & Figs. 11A-12B, ¶0049 & 0051) offset from said central axis of said baseplate (110, Fig. 10C). Regarding claim 21, Angibaud teaches wherein said central axis of said glenosphere is rotatable along a curve relative to said baseplate (Figs. 11A-12B, ¶0051). Regarding claim 22, Angibaud teaches wherein a central axis of said glenosphere is rotatable about a pivot axis over a range of between 50 degrees and 90 degrees ("variable angular orientation" means that a surgeon can intraoperatively adjust or change the angular orientation of the adjustment plate relative to the glenoid plate…adjustment plate may also be offset or lengthened to increase the degree of adjustability in order to optimize soft tissue tensioning which may be useful to modify the center of rotation in the cases of bone or soft tissue deficiencies in order to better tension the joint therefore, the degrees can be increased to between 60 and 80 degrees for optimal use, ¶0041). Regarding claim 23, Angibaud teaches further comprising a humeral implant system (Figs. 4A-4C). Regarding claim 24, Angibaud teaches wherein said humeral implant system (Figs. tiltable 4A-4C) comprises a humeral cup (104, Figs. 4A-4C) and a humeral stem (102, Figs. 4A-4C). Regarding claim 25, Angibaud teaches wherein said glenoid implant system comprises a central screw (112, Fig. 6C) and a plurality of peripheral screws (114, Fig. 8C) for securing said baseplate (110, Fig. 8C) to the glenoid of the patient (Fig. 11A, ¶0047). Regarding claim 36, Angibaud teaches wherein said central axis of said glenosphere is angularly movable relative to said central axis of said baseplate (¶0049). Regarding claim 37, Angibaud teaches a glenoid implant system (100, Figs. 4A-4C, ¶0044) for use in a reverse total shoulder replacement system (100, Figs. 4A-4C, ¶0044) of a patient, said glenoid implant system comprising: a glenosphere (108, Figs. 5A-5C) comprising a body and an articular surface (Fig. 5C); the body having a first portion and a second portion (see annotated Figs. 5A-5C below), the first portion having the articular surface (see annotated Figs. 5A-5C below), and the second portion having at least one curved surface positioned adjacent to a central axis of the body (top and bottom portions of second portion are curved, see annotated Fig. 5B below); a baseplate (110, Fig. 11A) fixedly attachable to a glenoid of the patient (Fig, 3A), said baseplate (110, Figs. 6A-6D) having a central axis (Fig. 6C); and a means (140, Fig. 10C) for movably connecting said glenosphere to said baseplate (108, Fig. 10B) so that said glenosphere (108, Fig. 10B) is movable non-coaxially relative to said baseplate (¶0049). Regarding claim 38, Angibaud teaches wherein said means (140, Fig. 10C) for movably connecting is operable, wherein said central axis of said glenosphere (108, 11A-12B) is tiltable relative to said baseplate (Figs. 11A-12B, ¶0051). Regarding claim 39, Angibaud teaches wherein said means (140, Fig. 10C) for movably connecting is operable, wherein said central axis of said glenosphere (108, 11A-12B) is tiltable along a plane relative to said baseplate (Figs. 11A-12B, ¶0051). Regarding claim 40, Angibaud teaches wherein said central axis of said glenosphere is tiltable over an angle of 10 degrees (12 degrees in each direction, 24 degrees in total, ¶0051), 20 degrees, 30 degrees, 45 degrees, 60 degrees, 70 degrees, or 90 degrees, a range of between 10 degrees and 30 degrees, a range of between 20 degrees and 50 degrees, or a range of between 30 degrees and 60 degrees ("variable angular orientation" means that a surgeon can intraoperatively adjust or change the angular orientation of the adjustment plate relative to the glenoid plate…adjustment plate may also be offset or lengthened to increase the degree of adjustability in order to optimize soft tissue tensioning which may be useful to modify the center of rotation in the cases of bone or soft tissue deficiencies in order to better tension the joint therefore, the degrees can be increased to between 60 and 80 degrees for optimal use, ¶0041). Regarding claim 43, Angibaud teaches wherein said central axis of said glenosphere is rotatable about a pivot axis over an angle of 10 degrees (12 degrees in each direction, 24 degrees in total, ¶0051), 20 degrees, 30 degrees, 45 degrees, 60 degrees, 70 degrees, or 90 degrees, a range of between 10 degrees and 30 degrees, a range of between 20 degrees and 50 degrees, or a range of between 30 degrees and 60 degrees ("variable angular orientation" means that a surgeon can intraoperatively adjust or change the angular orientation of the adjustment plate relative to the glenoid plate…adjustment plate may also be offset or lengthened to increase the degree of adjustability in order to optimize soft tissue tensioning which may be useful to modify the center of rotation in the cases of bone or soft tissue deficiencies in order to better tension the joint therefore, the degrees can be increased to between 60 and 80 degrees for optimal use, ¶0041). Regarding claim 44, Angibaud teaches further comprising a humeral implant system (Figs. 4A-4C). Regarding claim 45, Angibaud teaches further comprising a humeral implant system comprising a humeral cup (104, Figs. 4A-4C) and a humeral stem (102, Figs. 4A-4C). Regarding claim 46, Angibaud teaches wherein said glenoid implant system comprises a central screw (112, Fig. 6C) and a plurality of peripheral screws (114, Fig. 8C) for securing said baseplate (110, Fig. 8C) to the glenoid (Fig. 11A, ¶0047). Regarding claim 47, Angibaud teaches wherein said central axis of said glenosphere (108, Fig. 10B) is movable around a pivot axis (142, Figs. 9A & Figs. 11A-12B, ¶0049 & 0051). Regarding claim 48, Angibaud teaches wherein said body of said glenosphere (108, Figs. 5A-5C) comprises a passageway (seen in Fig. 5B) from said first portion to said second portion, and said means (140, Fig. 10C) for movably connecting is extendable through said passageway for pivotally connecting said glenosphere about said pivot axis (142, Figs. 9A & Figs. 11A-12B, ¶0049 & 0051). Regarding claim 49, Angibaud teaches wherein said second portion of said glenosphere comprises a flat surface facing said baseplate (side portions of second portion is flat, Figs. 5A-5B). Regarding claim 50, Angibaud teaches wherein said second portion of said glenosphere comprises a curved slot (118 forms a recessed track extending into second portion, Fig. 5B, ¶0045) facing said baseplate (110, Figs. 11-12), and said baseplate comprises a post (see annotated Fig. 6C below) receivable in said curved slot (Fig. 10C). Regarding claim 51, Angibaud does not teache wherein said central axis of said glenosphere is movable around said pivot axis of between 60 degrees and 80 degrees It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the pivot axis of between 60 and 80 degrees since these are result effective variables that contribute to the overall variable angular orientation. It has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art and modifying the range to between 60 and 80 degrees would increase the degree of adjustability in order to optimize soft tissue tensioning as suggested by Angibaud (¶0041). Regarding claim 52, Angibaud does not teache wherein a central axis of said glenosphere is tiltable relative to said central axis of said baseplate over a range of between 30 degrees and 60 degrees It would have been obvious to one having ordinary skill in the art at the time the invention was made to modify the tiltable relative to said central axis of said baseplate between 30 and 60 degrees since these are result effective variables that contribute to the overall variable angular orientation. It has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art and modifying the range to between 30 and 60 degrees would increase the degree of adjustability in order to optimize soft tissue tensioning as suggested by Angibaud (¶0041). PNG media_image1.png 394 712 media_image1.png Greyscale PNG media_image2.png 242 232 media_image2.png Greyscale Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KIA XIONG WHITE whose telephone number is (703)756-4773. The examiner can normally be reached 0830-1630 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached at (408) 918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /K.X.W./Examiner, Art Unit 3774 /YASHITA SHARMA/Primary Patent Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

May 11, 2022
Application Filed
Aug 01, 2025
Non-Final Rejection mailed — §102
Dec 01, 2025
Response Filed
May 15, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551344
HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFOR
4y 6m to grant Granted Feb 17, 2026
Patent 12544222
GUIDE WIRE APPARATUSES AND METHODS
4y 6m to grant Granted Feb 10, 2026
Patent 12521260
RELEASABLE KNOTS FOR MEDICAL DEVICE DELIVERY
4y 11m to grant Granted Jan 13, 2026
Patent 12514722
CAROTID ARTERY STENTING SYSTEMS AND METHODS
4y 5m to grant Granted Jan 06, 2026
Patent 12502294
MEDICAL DEVICE DELIVERY
4y 9m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+51.9%)
3y 10m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 40 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month